Total Payments
$22,690
2024 Payments
$2,979
Companies
74
Transactions
1,468
Medicare Patients
2,560
Medicare Billing
$212,886
Payment Breakdown by Category
Food & Beverage$22,546 (99.4%)
Education$144.45 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,546 | 1,452 | 99.4% |
| Education | $144.45 | 16 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,098 | 189 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,603 | 132 | $0 (2024) |
| ABBVIE INC. | $1,821 | 140 | $0 (2024) |
| Lilly USA, LLC | $1,669 | 125 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,406 | 92 | $0 (2024) |
| Amgen Inc. | $1,401 | 92 | $0 (2024) |
| Amarin Pharma Inc. | $907.42 | 63 | $0 (2023) |
| Merck Sharp & Dohme LLC | $814.12 | 70 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $805.85 | 71 | $0 (2023) |
| GlaxoSmithKline, LLC. | $734.81 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,979 | 164 | AstraZeneca Pharmaceuticals LP ($612.06) |
| 2023 | $3,487 | 209 | ABBVIE INC. ($533.85) |
| 2022 | $2,579 | 165 | ABBVIE INC. ($429.68) |
| 2021 | $2,673 | 164 | AbbVie Inc. ($430.04) |
| 2020 | $2,620 | 165 | Novo Nordisk Inc ($413.99) |
| 2019 | $2,516 | 191 | Novo Nordisk Inc ($438.84) |
| 2018 | $3,047 | 209 | Novo Nordisk Inc ($626.00) |
| 2017 | $2,788 | 201 | Novo Nordisk Inc ($725.73) |
All Payment Transactions
1,468 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 493 | 861 | $107,011 | $44,727 |
| 2022 | 11 | 703 | 1,085 | $100,825 | $53,739 |
| 2021 | 17 | 623 | 1,059 | $116,494 | $62,891 |
| 2020 | 18 | 741 | 1,281 | $118,095 | $51,528 |
Total Patients
2,560
Total Services
4,286
Medicare Billing
$212,886
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 302 | $54,824 | $23,776 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $13,806 | $8,107 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 131 | $16,620 | $5,585 | 33.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $9,122 | $3,644 | 39.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 38 | $3,990 | $1,408 | 35.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $2,208 | $872.46 | 39.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 12 | 12 | $2,172 | $646.92 | 29.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 59 | $1,972 | $504.54 | 25.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $524.00 | $119.13 | 22.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 11 | 17 | $243.00 | $54.57 | 22.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 28 | 150 | $1,530 | $10.75 | 0.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 283 | $38,986 | $22,532 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $19,598 | $12,647 | 64.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 205 | $20,090 | $9,480 | 47.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,590 | $2,598 | 56.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 132 | 132 | $5,808 | $2,328 | 40.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 15 | 38 | $3,990 | $1,416 | 35.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 20 | 20 | $2,000 | $1,405 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $969.00 | $711.24 | 73.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 58 | $1,914 | $497.70 | 26.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $768.00 | $109.56 | 14.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 34 | 192 | $2,112 | $14.39 | 0.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 325 | $44,850 | $26,057 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 134 | 220 | $21,560 | $11,492 | 53.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $15,600 | $10,317 | 66.1% |
About Dr. Carlos Munoz, M.D
Dr. Carlos Munoz, M.D is a Family Medicine healthcare provider based in Richmond, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043269285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Munoz, M.D has received a total of $22,690 in payments from pharmaceutical and medical device companies, with $2,979 received in 2024. These payments were reported across 1,468 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($22,546).
As a Medicare-enrolled provider, Munoz has provided services to 2,560 Medicare beneficiaries, totaling 4,286 services with total Medicare billing of $212,886. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Richmond, TX
- Active Since 05/06/2006
- Last Updated 08/12/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043269285
Products in Payments
- JARDIANCE (Drug) $1,571
- FARXIGA (Drug) $1,491
- Ozempic (Drug) $1,257
- Vascepa (Drug) $907.42
- ZENPEP (Drug) $889.57
- Victoza (Drug) $858.23
- XARELTO (Drug) $792.99
- VRAYLAR (Drug) $734.25
- TRULICITY (Drug) $727.06
- Kerendia (Drug) $650.46
- UBRELVY (Drug) $645.50
- MOUNJARO (Drug) $567.23
- XIFAXAN (Drug) $521.38
- JANUVIA (Drug) $477.92
- TRELEGY ELLIPTA (Drug) $450.52
- ELIQUIS (Drug) $430.44
- SYMBICORT (Drug) $356.95
- Prolia (Biological) $346.47
- Otezla (Drug) $338.74
- AIRSUPRA (Drug) $338.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Richmond
Jan Diamond, Md, MD
Family Medicine — Payments: $226,571
Family Medicine $226,571
Edwin Robinson, Md, MD
Family Medicine — Payments: $144,986
Family Medicine $144,986
Dr. Ivan Mefford, Md, MD
Family Medicine — Payments: $117,040
Family Medicine $117,040
Dr. Paul Stairs, Md, MD
Family Medicine — Payments: $84,850
Family Medicine $84,850
Mary Gauthier, M.d, M.D
Family Medicine — Payments: $30,050
Family Medicine $30,050
James Foster, M.d, M.D
Family Medicine — Payments: $29,307
Family Medicine $29,307